Prevalence of the metabolic syndrome in patients with carotid disease according to NHLBI/AHA and IDF criteria: a cross-sectional study

<p>Abstract</p> <p>Background</p> <p>Metabolic syndrome (MetS) has been related to type 2 diabetes and cardiovascular diseases. Different criteria for diagnosis of MetS have been recommended, but there is no agreement about which criteria are best to use. The aim of the...

Full description

Bibliographic Details
Main Authors: Maksimovic Milos Z, Vlajinac Hristina D, Radak Djordje J, Marinkovic Jelena M, Jorga Jagoda B
Format: Article
Language:English
Published: BMC 2012-01-01
Series:BMC Cardiovascular Disorders
Subjects:
Online Access:http://www.biomedcentral.com/1471-2261/12/2
_version_ 1828543910021955584
author Maksimovic Milos Z
Vlajinac Hristina D
Radak Djordje J
Marinkovic Jelena M
Jorga Jagoda B
author_facet Maksimovic Milos Z
Vlajinac Hristina D
Radak Djordje J
Marinkovic Jelena M
Jorga Jagoda B
author_sort Maksimovic Milos Z
collection DOAJ
description <p>Abstract</p> <p>Background</p> <p>Metabolic syndrome (MetS) has been related to type 2 diabetes and cardiovascular diseases. Different criteria for diagnosis of MetS have been recommended, but there is no agreement about which criteria are best to use. The aim of the present study was to investigate agreement between the National Heart, Lung, and Blood Institute, American Heart Association (NHLBI/AHA) and the International Diabetes Federation (IDF) definitions of MetS in patients with symptomatic carotid disease and to compare the frequency of cardiovascular risk factor in patients with MetS diagnosed by these two sets of criteria.</p> <p>Methods</p> <p>The study was a cross-sectional one involving 644 consecutive patients with verified carotid disease who referred to the Vascular Surgery Clinic Dedinje in Belgrade during the period April 2006 - November 2007. Anthropometric parameters blood pressure, fasting plasma glucose and lipoproteins were measured using standard procedures.</p> <p>Results</p> <p>MetS was present in 67.9% of participants, according to IDF criteria, and in 64.9% of participants, according to the NHLBI/AHA criteria. A total of 119 patients were categorized differently by the two definitions. Out of all participants 10.7% had MetS by IDF criteria only and 7.8% of patients had MetS by NHLBI/AHA criteria only. The overall agreement of IDF and NHLBI/AHA criteria was 81.5% (Kappa 0.59, <it>p </it>< 0.001). In comparison with patients who met only IDF criteria, patients who met only NHLBI/AHA criteria had significantly more frequently cardiovascular risk factors with the exception of obesity which was significantly more frequent in patients with MetS diagnosed by IDF criteria.</p> <p>Conclusion</p> <p>The MetS prevalence in patients with symptomatic carotid disease was high regardless of criteria used for its diagnosis. Since some patients with known cardiovascular risk factors were lost by the use of IDF criteria it seems that NHLBI/AHA definition is more suitable for diagnosis of MetS. Large follow-up studies are needed to test prognostic value of these definitions.</p>
first_indexed 2024-12-12T02:22:08Z
format Article
id doaj.art-153d719b32ad4b2cac70d6e13cb3afa0
institution Directory Open Access Journal
issn 1471-2261
language English
last_indexed 2024-12-12T02:22:08Z
publishDate 2012-01-01
publisher BMC
record_format Article
series BMC Cardiovascular Disorders
spelling doaj.art-153d719b32ad4b2cac70d6e13cb3afa02022-12-22T00:41:39ZengBMCBMC Cardiovascular Disorders1471-22612012-01-01121210.1186/1471-2261-12-2Prevalence of the metabolic syndrome in patients with carotid disease according to NHLBI/AHA and IDF criteria: a cross-sectional studyMaksimovic Milos ZVlajinac Hristina DRadak Djordje JMarinkovic Jelena MJorga Jagoda B<p>Abstract</p> <p>Background</p> <p>Metabolic syndrome (MetS) has been related to type 2 diabetes and cardiovascular diseases. Different criteria for diagnosis of MetS have been recommended, but there is no agreement about which criteria are best to use. The aim of the present study was to investigate agreement between the National Heart, Lung, and Blood Institute, American Heart Association (NHLBI/AHA) and the International Diabetes Federation (IDF) definitions of MetS in patients with symptomatic carotid disease and to compare the frequency of cardiovascular risk factor in patients with MetS diagnosed by these two sets of criteria.</p> <p>Methods</p> <p>The study was a cross-sectional one involving 644 consecutive patients with verified carotid disease who referred to the Vascular Surgery Clinic Dedinje in Belgrade during the period April 2006 - November 2007. Anthropometric parameters blood pressure, fasting plasma glucose and lipoproteins were measured using standard procedures.</p> <p>Results</p> <p>MetS was present in 67.9% of participants, according to IDF criteria, and in 64.9% of participants, according to the NHLBI/AHA criteria. A total of 119 patients were categorized differently by the two definitions. Out of all participants 10.7% had MetS by IDF criteria only and 7.8% of patients had MetS by NHLBI/AHA criteria only. The overall agreement of IDF and NHLBI/AHA criteria was 81.5% (Kappa 0.59, <it>p </it>< 0.001). In comparison with patients who met only IDF criteria, patients who met only NHLBI/AHA criteria had significantly more frequently cardiovascular risk factors with the exception of obesity which was significantly more frequent in patients with MetS diagnosed by IDF criteria.</p> <p>Conclusion</p> <p>The MetS prevalence in patients with symptomatic carotid disease was high regardless of criteria used for its diagnosis. Since some patients with known cardiovascular risk factors were lost by the use of IDF criteria it seems that NHLBI/AHA definition is more suitable for diagnosis of MetS. Large follow-up studies are needed to test prognostic value of these definitions.</p>http://www.biomedcentral.com/1471-2261/12/2metabolic syndromecarotid diseaserisk factors
spellingShingle Maksimovic Milos Z
Vlajinac Hristina D
Radak Djordje J
Marinkovic Jelena M
Jorga Jagoda B
Prevalence of the metabolic syndrome in patients with carotid disease according to NHLBI/AHA and IDF criteria: a cross-sectional study
BMC Cardiovascular Disorders
metabolic syndrome
carotid disease
risk factors
title Prevalence of the metabolic syndrome in patients with carotid disease according to NHLBI/AHA and IDF criteria: a cross-sectional study
title_full Prevalence of the metabolic syndrome in patients with carotid disease according to NHLBI/AHA and IDF criteria: a cross-sectional study
title_fullStr Prevalence of the metabolic syndrome in patients with carotid disease according to NHLBI/AHA and IDF criteria: a cross-sectional study
title_full_unstemmed Prevalence of the metabolic syndrome in patients with carotid disease according to NHLBI/AHA and IDF criteria: a cross-sectional study
title_short Prevalence of the metabolic syndrome in patients with carotid disease according to NHLBI/AHA and IDF criteria: a cross-sectional study
title_sort prevalence of the metabolic syndrome in patients with carotid disease according to nhlbi aha and idf criteria a cross sectional study
topic metabolic syndrome
carotid disease
risk factors
url http://www.biomedcentral.com/1471-2261/12/2
work_keys_str_mv AT maksimovicmilosz prevalenceofthemetabolicsyndromeinpatientswithcarotiddiseaseaccordingtonhlbiahaandidfcriteriaacrosssectionalstudy
AT vlajinachristinad prevalenceofthemetabolicsyndromeinpatientswithcarotiddiseaseaccordingtonhlbiahaandidfcriteriaacrosssectionalstudy
AT radakdjordjej prevalenceofthemetabolicsyndromeinpatientswithcarotiddiseaseaccordingtonhlbiahaandidfcriteriaacrosssectionalstudy
AT marinkovicjelenam prevalenceofthemetabolicsyndromeinpatientswithcarotiddiseaseaccordingtonhlbiahaandidfcriteriaacrosssectionalstudy
AT jorgajagodab prevalenceofthemetabolicsyndromeinpatientswithcarotiddiseaseaccordingtonhlbiahaandidfcriteriaacrosssectionalstudy